| 2022-11-30 | Sale | Akero Therapeutics, Inc. AKRO | director | 23,131 0.0499% | $46.94 | $1.09M | -3.51% | |
| 2022-10-28 | Sale | Akero Therapeutics, Inc. AKRO | director | 44,103 0.0932% | $40.31 | $1.78M | +10.27% | |
| 2022-10-27 | Sale | Akero Therapeutics, Inc. AKRO | director | 138,598 0.3005% | $41.53 | $5.76M | +9.82% | |
| 2022-10-26 | Sale | Akero Therapeutics, Inc. AKRO | director | 137,468 0.301% | $43.75 | $6.01M | +5.33% | |
| 2022-10-25 | Sale | Akero Therapeutics, Inc. AKRO | director | 9,421 0.0206% | $44.92 | $423,156 | +2.42% | |
| 2020-11-24 | Stoke Therapeutics, Inc. STOK | 375,000 0.9287% | $39.00 | $14.63M | -27.6% | |||
| 2020-07-10 | Akero Therapeutics, Inc. AKRO | 830,000 2.3328% | $36.00 | $29.88M | -22.54% | |||
| 2019-06-24 | Akero Therapeutics, Inc. AKRO | 1.8M 46.2798% | $16.00 | $28.8M | +13.18% | |||
| 2019-06-21 | Stoke Therapeutics, Inc. STOK | 1.39M 18.0204% | $18.00 | $25M | -8.54% | |||
| 2014-09-22 | Eledon Pharmaceuticals, Inc. ELDN | 362,500 12.71% | $15.00 | $5.44M | -25.73% |